To identify the proteins associated with soluble ␣-synuclein (AS) that might promote AS aggregation, a key event leading to neurodegeneration, we quantitatively compared protein profiles of AS-associated protein complexes in MES cells exposed to rotenone, a pesticide that produces parkinsonism in animals and induces Lewy body (LB)-like inclusions in the remaining dopaminergic neurons, and to vehicle. We identified more than 250 proteins associated with Nonidet P-40 soluble AS, and demonstrated that at least 51 of these proteins displayed significant differences in their relative abundance in AS complexes under conditions where rotenone was cytotoxic and induced formation of cytoplasmic inclusions immunoreactive to anti-AS. Overexpressing one of these proteins, heat shock protein (hsp) 70, not only protected cells from rotenonemediated cytotoxicity but also decreased soluble AS aggregation. Furthermore, the protection afforded by hsp70 transfection appeared to be related to suppression of rotenone-induced oxidative stress as well as mitochondrial and proteasomal dysfunction.
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␣-Synuclein (AS)
1 is a neuronal protein of unknown function that is normally localized to presynaptic terminals in mammalian brain. Pathologically, it has been found to be a major constituent of Lewy bodies (LBs) in both Parkinson's disease (PD) and dementia with Lewy bodies (DLB) as well as other neurodegenerative diseases (1) . Three types of AS missense mutations (A30P (2), A53T (3), and E46K (4)) that co-segregate with clinical manifestations of PD in autosomal-dominantly inherited familial PD have been found. The fact that each mutation appears to make the protein prone to aggregation strongly implicates AS aggregation in neuronal degeneration. Although there are no known AS mutations in sporadic PD, AS aggregation is also believed to be pivotal in pathogenesis in these patients (5) . For sporadic PD, it is currently hypothesized that dysfunction of the ubiquitin-proteasome system (UPS) (6) and interrelated increased oxidative stress (7) lead to inappropriate folding and aggregation of AS, eventually resulting in cell death.
Although the mechanism whereby mutations or oxidatively damaged AS lead to AS aggregation is not completely understood; one of the prevailing hypotheses is that mutated or damaged AS first forms soluble oligomers, followed by insoluble fibrils such as those found in LBs. These protein aggregates are refractory to UPS-mediated proteolysis, thus ultimately leading to cell death (8) . More recently, it has been demonstrated that soluble AS oligomers are more toxic than insoluble fibrils (9, 10) in cell culture models. Consistent with this hypothesis, both A53T and A30P mutations induce more rapid formation of AS oligomers (reviewed in Ref. 11) , although the A30P mutation demonstrates a slower rate of fibrillization than wild-type AS. Indeed, these findings were the basis for the proposed toxic role of small AS oligomers and led to the development of the working model proposed by Lansbury and coworkers (9, 12) , in which molecular crowding, i.e. focally increased AS concentration in the cytosol, accelerates the formation of AS protofibrils. These protofibrils become toxic as they bind to and permeate lipid vesicles or membranes and then form insoluble fibrils.
The processes leading to molecular crowding of AS and subsequent aggregation, though largely unknown, can be influenced by macromolecules like inert polymers (13) . Proteins interacting with AS may also modulate the extent of molecular crowding of AS, thereby influencing its ability to form aggregates. For example, a mutation in parkin, an E3 ligase interacting with AS, leads to neuronal death in the absence of LB formation (14) . Over the last 10 years, numerous investigators have utilized a variety of approaches to identify the proteins interacting with AS; about 30 proteins have been found that either interact with AS directly in vitro or are associated with LBs in human PD (1, 10, 15) . To comprehensively study the proteins associated with AS, particularly in the context of soluble AS aggregate formation, we have employed quantitative proteomics in conjunction with isotope-coded affinity tags (ICAT) (16, 17) . Using this technique we quantified changes in the protein complex associated with AS in a dopaminergic cell line, MES cells, exposed to rotenone, a pesticide that not only produces parkinsonism in animal models but also induces formation of LB-like inclusions in the remaining dopaminergic neurons (18) . We specifically focused on soluble AS aggregates, because they appear to play a key role in AS aggregationinduced toxicity. Finally, we studied the biological function of one AS-associated protein whose level in the protein complex was significantly lowered by exposure to rotenone.
EXPERIMENTAL PROCEDURES
Chemicals and Antibodies-All reagents were purchased from Sigma unless otherwise specified. Antibodies used included: AS (13623, a gift from Drs. Pedro Piccardo and Bernardino Ghetti at Indiana University and widely used in neurodegenerative research (18, 19) ); a second AS (5038, Chemicon, Temecula, CA); hsp70 and glucose-regulated protein (Grp94) (Stressgen Biotechnologies, Victoria, BC); cytochrome c (BD PharMingen, San Diego, CA); Calnexin (Sigma).
Cell Cultures and Viability Assays-Detailed methods for culturing MES cells, a gift from Drs. Weidong Le and Stanley Appel at Baylor University, have been previously described by us (20) . Two viability assays were used: live-dead and MTT. Both were performed according to the manufacturer's instructions (Molecular Probes, Eugene, OR and Roche Applied Science, respectively). In selected experiments, remaining viable cells were directly counted after trypan blue staining as indicated. Finally, cell viability of cells transfected with hsp70 was assessed by flow cytometry as described below.
Immunocytochemistry-AS-associated protein aggregation in cells exposed to rotenone was determined using polyclonal anti-AS (13623; 1:300). In brief, cells were cultured on chambered glass slides (Nalge Nunc, Naperville, IL) and treated with 20 nM rotenone or vehicle (0.1% Me 2 SO) for 3 days. After treatment, cells were fixed in 4% paraformaldehyde followed by incubation with formic acid. Fixed cells were incubated with primary antibody overnight at 4°C, followed by incubation with cross-adsorbed goat anti-rabbit antibody to reveal AS after DAB reaction and counterstained with H&E.
Western Blot-Cells were extracted with ice-cold Nonidet P-40 lysis buffer (150 mM NaCl, 0.5% Nonidet P-40, 50 mM Tris, pH 8.0) and a mixture of protease and phosphatase inhibitors. Lysates were then centrifuged for 10 min at 14,000 ϫ g at 4°C; 40 g of protein from each supernatant was subjected to 12% SDS-PAGE and transferred to polyvinylidene difluoride, blocked, and probed overnight at 4°C with rabbit anti-AS (13623 at 1:10,000; or 5038, 1:5,000). Peroxidase-conjugated secondary antibody was added at 1:40,000, and developed with enhanced chemiluminescence. AS aggregation was quantified by measuring optical densities of the high molecular bands (two bands in Fig.  1C indicated by open and closed arrows), whereas total AS was calculated by adding the optical densities of all anti-AS positive bands.
In-gel Digestion and LC-MS Characterization of Protein ComplexesDuplicate gels were run with one gel blotted and probed with anti-AS while the other gel was stained with Coomassie Blue. Stained gel sections corresponding to AS-immunoreactive bands in Western blot analysis were cut and digested as described previously (21) . Next, extracted peptides were desalted by reversed-phase ZipTip (Millipore, Bedford, MA) and injected onto an LC-MS/MS LCQ DECA workstation (see below). Each sample was injected twice, and 12 possible AS peptides generated from trypsin digestion were monitored using SIM.
Isolation of AS-associated Protein Complex-An NHS AS affinity column was prepared following manufacturer's instruction (Amersham Biosciences). Nonidet P-40 soluble fractions were prepared from 2.0 ϫ 10 8 cells by gentle Dounce homogenization in Nonidet P-40 lysis buffer, followed by centrifugation at 14,000 ϫ g to remove organelles. Supernatant was loaded onto the affinity column (0.2 ml/min) and washed with binding buffer (50 mM Tris-HCl, pH 7.4). Bound AS and its associated proteins were eluted with 100 mM glycine-HCl and 0.5 M NaCl at pH 2.7 and desalted with a PD-10 desalting column (Amersham Biosciences). Protein concentration was determined by standard BCA assay, and the presence of AS was confirmed by Western blot analysis as described above. These protein complexes were used for ICAT analysis described below.
To determine the extent of possible contamination in the Nonidet P-40 AS protein complex by proteins from other organelles, relative abundance of several organelle protein markers was determined in Nonidet P-40 soluble lysates using Western blot analysis as described above. Markers analyzed included cytochrome c and cytochrome c oxidase (COX) (mitochondria, 1:10,000), calnexin (ER, 1:10,000), and glucose-regulated protein (Grp94, lysosome, 1:6000).
ICAT Analysis of Protein Complexes with LC Followed by MS-ICAT labeling was performed as described initially by Gygi et al. (16) and to the manufacturer's specifications (Applied Biosystems, Foster City, CA). Recently, we have also used this technique to quantitatively analyze the proteome of human cerebrospinal fluid (CSF) (17) . Briefly, AS protein complexes isolated as described above from either rotenone-or vehicle-treated cells (100 g of protein each) were reduced, and cysteinyl groups biotinylated with a 5-fold molar excess of either heavy ( 13 C) (rotenone) or light ( 12 C) (Me 2 SO) cleavable ICAT reagents. Next, the two labeled samples were mixed, digested with trypsin (Promega, Madison, WI) overnight at 37°C, and the digested peptide solution was passed consecutively over an ionic exchange column and a monomeric avidin column (Applied Biosystem). The biotinylated peptides were eluted with 0.3% trifluoroacetic acid in 30% acetonitrile, and biotin was cleaved from the labeled peptides with concentrated trifluoroacetic acid. Finally, the purified labeled peptides were separated and analyzed with a LC system linked directly to two alternating reversed-phase C18 columns (10 cm ϫ 180 m), followed by analysis with MS/MS (ThermoFinnigan, San Jose, CA). Settings for the LC-MS/MS were as follows: 12 fractions were eluted from SCX using a binary gradient of 2-90% solvent D (1.0 M ammonium chloride and 0.1% formic acid in 5% acetonitrile) versus solvent C (0.1% formic acid in 5% acetonitrile). Each fraction was injected automatically onto a reverse phase column with peptides resolved using a 200-min binary gradient of 5-80% solvent B (acetonitrile and 0.1% formic acid) versus solvent A (0.1% formic acid in water). A flow rate of 160 l/min with a spit ratio of 2 l was used. The intensities of eluting peptide pairs (heavy versus light) were measured in the scanning mass spectrometer. To determine the amino acid sequence, the MS operated in a data-dependent MS/MS mode, where the precursor ion was selected "on the fly" from the previous scan. An m/z ratio for an ion that had been selected for fragmentation was placed on a list and dynamically excluded for 3 min from further fragmentation. Proteins from the mixture were later identified automatically using the computer program Sequest, which searched MS/MS spectra against the International Proteins Index database (22) (23) (24) . Potential peptides and proteins were further analyzed by newly developed computer software to select proteins with high probability of being correct (Ͻ 5% error rate) (25) . Relative protein abundance in experimental groups compared with controls was calculated using a newly developed computer algorithm, the Automated Statistical Analysis of Protein abundance (ASAP) ratio.
Immunoprecipitation of hsp70 -Reverse hsp70 immunoprecipitation was performed as described previously (26) with minor modifications. These included: 1% Triton X-100 in PBS (pH 7.4); centrifugation at 10,000 ϫ g for 15 min; primary monoclonal mouse anti-hsp70 antibody incubation at 4°C for 2 h; and immunoblotting with AS antibody (5038, 1:5,000).
Transfection of hsp70 and Selection by Flow Cytometry-Vector pZEM-hsp70-tag was a gift from Dr. Kerstin Bellmann (Centre de Recherche en Cancérologie de l'Université Laval, Montreal, QC). Transfection was performed as described by others (27) and to the manufacturer's specification (LipofectAMINE Plus TM , Life Technologies, Carlsbad, CA). Clones with high hsp70 expression levels were selected by flow cytometry using anti-hsp70, and replated to form stable cell lines. Notably, while hsp70 levels in the selected clones, as assessed by Western blot, were significantly increased (300% over vector-transfected cells), only about 30% of cells demonstrated apparent increase in hsp70 levels as determined by flow cytometry (also see Fig. 5C 1 ) .
Flow Cytometric Characterization of hsp70 Cells-FITC-TUNEL/ hsp70 dual labeling was used to correlate cell death (apoptosis) and hsp70 expression level in hsp70-transfected cells. Briefly, at 3 days post-rotenone or vehicle treatment, cells Ϯ hsp70 transfection were collected, washed twice with PBS, and fixed in 2% paraformaldehyde for 1 h before treatment with 0.1% Triton X-100 in 0.1% sodium citrate for 2 min on ice. Apoptosis was assayed by TUNEL labeling as per the manufacturer's instructions (Roche Applied Science). After washing twice with 2% fetal bovine serum in PBS, pH 7.4, cells were incubated with mouse anti-hsp70 at room temperature for 30 min, then donkey anti-mouse IgG conjugated with phycoerythrin (PE) (Jackson ImmunoResearch Laboratories, West Grove, PA). Simultaneous measurement of TUNEL intensity and hsp70 expression level was carried out using a FACSort® flow cytometer (BD Biosciences).
Measurement of Mitochondrial Complex I Activity-Mitochondria were isolated and assayed for complex I activity using previously described methods (28) . Briefly, complex I (NADH: ubiquinone oxidoreductase) activity was measured by monitoring loss of absorbance at 340 nm (⑀: 6.81 mM
Proteasomal Activity Assay-20 S chymotrypsin-like and postglutamyl peptidase proteasomal activities were determined as previously described by measuring the fluorescence of 7-amido-4-methylcoumarin (AMC) liberated from peptide-AMC linked substrates (6) . The results, expressed as fluorescence units (FU)/min/mg protein, were normalized to inhibition of total proteasomal function by 10 M lactacystin.
Protein Carbonyl Assay-Protein oxidation was measured by quantifying total protein carbonyl contents using DNPH. The spectrum difference between DNPH-treated and control samples was determined, and results were expressed as nanomoles of DNPH incorporated/mg of protein based on the absorption at 375 nm (⑀: 21.0 mM Ϫ1 ⅐cm Ϫ1 ). Protein concentration was determined by standard BCA assay.
Statistical Methods-Grouped data are expressed as mean Ϯ S.E. Changes between groups were analyzed by one-way analysis of variance (ANOVA) and Newman-Keuls test using GraphPad Prism 3.0 (San Diego, CA). Repeated measures were performed at least three times in all experiments. p Ͻ 0.05 was accepted as significant.
RESULTS
Characterization of Rotenone-produced Neurotoxicity-Rotenone produced time-and dose-dependent cytotoxicity in cells, with ϳ40% remaining viable (as determined by live-dead assay) following a 3-day treatment with 20 nM rotenone (Fig. 1A) . Treatment with vehicle (0.1% Me 2 SO) produced minimal toxicity. Viability assessed by MTT assay as well as direct enumeration of viable cells after trypan blue staining gave similar results (data not shown). Remarkably, rotenone-treated cells also demonstrated formation of cytoplasmic LB-like inclusions (Fig. 1B ) that were immunoreactive with anti-AS (inset in Fig.  1B ). In addition, there was an apparent shift toward higher molecular weight Nonidet P-40 soluble AS immunoreactive bands (Fig. 1C ). Semiquantitative analysis of the two highest molecular weight bands demonstrated that rotenone exposure produced a 10-fold increase in AS aggregation. Although overall levels of AS did not change significantly in rotenone-treated cells as compared with vehicle-treated cells, the increase in AS aggregation appeared to be accompanied by a decrease in AS monomer (band near 17.8 kDa) and a few AS complexes or aggregates (within right brace in Fig. 1C ) that were present in vehicle-treated cells. The nature of these complexes or aggregates is not known; however, the presence of AS was confirmed by Western blot analysis with another antibody targeted at a different amino acid sequence (13623). As further confirmation, duplicate gels were run and one gel blotted and probed with anti-AS while the other gel was stained with Coomassie Blue. Gel sections corresponding to those in Western blot analysis (Fig. 1C) were excised, digested with trypsin, separated by microcapillary liquid chromatography (LC), and analyzed with MS. 12 possible trypsin-generated AS peptides, which cover ϳ90% of AS sequence, were analyzed using selective ion monitoring (SIM) techniques. All analyzed bands contained from 8 to 12 selected ions (data not shown). Fig. 1D shows the sequence (in blue) for AS with peptides identified from in-gel digestion of the band area indicated by the closed arrow in Fig.  1C ; in this particular study, 10 of 12 selected ions were captured.
Exposure to Rotenone Significantly Modified the Compositions of the Protein Complex Associated with AS-To quantita-
tively compare the profiles of the Nonidet P-40 soluble AS protein complexes in rotenone-treated versus vehicle-treated cells, AS-associated proteins were purified by affinity chromatography, labeled with ICAT, and separated by LC followed by identification with MS/MS. This method identified 251 proteins (see Supplementary Materials I), many more than all the proteins previously reported in the literature combined (Table  I ). The MS scan and MS/MS fragmentation of a typical protein by LC-MS/MS are demonstrated in Fig. 2 . We were able to identify not only the majority of proteins reported to be associated with AS or co-localized to LBs in PD patients, but also several relevant to neurodegeneration or PD pathogenesis but not yet identified with either AS or LBs, e.g. hsp90. Notably, a significant number of proteins listed in Supplementary Mate- rials I were novel without known functions. Fig. 3 shows a pie chart summarizing the functions of the AS-associated proteins. Major classes of proteins included those related to signal transduction, UPS, regulation of oxidative stress, and mitochondrial function, all of which have been implicated in PD pathogenesis.
Of note, all proteins listed in Appendix I were identified with the software tools PeptideProphet and ProteinProphet (25) , and only proteins with at least two different peptide hits were considered. For instance, proteasomal subunit 4 and parkin, two proteins known to be important to PD, were not included in Table I or Supplementary Materials I, because they were identified by a single peptide only, even though they had good probability scores and altered abundance (see below) in cells treated with rotenone versus vehicle. Finally, although most protein identifications were unequivocal, some could not be distinguished based on the peptides present in the samples. These are listed as one group with several subentries in Table  II and Supplementary Materials I. Affinity purification, though a powerful method to analyze all possible proteins associated with AS protein complexes, can yield false positive results when proteins stick to AS during affinity purification. To address this issue, we used very gentle Dounce homogenization and monitored our fractionation procedure by measuring two mitochondrial markers, COX and cytochrome c, in the supernatant versus pellet following centrifugation. Our results demonstrated that less than 1% of the total amount of these markers was present in the supernatant. We deliberately chose a procedure that retained the majority of lysosomes and endoplasmic reticulum (ER) in the cytosol before affinity purification, since AS is usually associated with these organelles under both normal and stressed conditions (29, 30) . We confirmed that 84.47 and 82.76%, of lysosome and ER markers, respectively, were present in the supernatant. We further confirmed these observations by omitting Nonidet P-40 from the lysis buffer and centrifuging at 100,000 ϫ g, which decreased lysosome and ER components in the cytosol fraction (Ͻ 3 and 7% of total amount, respectively) but at the expense of loss of AS (data not shown).
It should be noted that with current LC-MS/MS technology, ϳ30% reproducibility is typically achieved when identical samples with moderate complexity are repeatedly analyzed (17, 31) . This is largely because the MS/MS spectrometer only fragments and consequently identifies a small fraction of the peptides captured by the first stage of any given MS scan. For this reason, we combined all proteins identified from four independent experiments; proteins identified in more than two independent experiments are indicated with an asterisk in Supplementary Materials as well as in Table II . Finally, it is important to note that proteins without cysteine residues, including AS, cannot be identified with this approach, because they do not react with ICAT reagents.
Despite the fact that the protein profile in each ICAT experiment may vary when complex protein mixtures are analyzed (31), quantitative information is valid when the same peptide is detected in paired samples at the same time. This is because MS will look for the corresponding peptide (e.g. light if heavy is captured) with very high sensitivity. By combining all four experiments and excluding all single hits, we identified numerous AS-associated proteins that displayed substantial quantitative differences in relative abundance between AS complexes in cells treated with rotenone versus vehicle. As a first step of data analysis, we separated proteins into four groups: proteins whose levels: 1) decreased Ͼ100%, 2) decreased Ͼ50%, 3) increased Ͼ100%, or 4) increased Ͼ50% when 100 g of protein of affinity-purified AS complexes from rotenone-treated cells was paired with 100 g from vehicle-treated cells (Table II) . Among the proteins whose levels changed significantly in rotenone-treated cells, hsps (categorized as UPS-related proteins in Fig. 3 ) appeared to comprise one of the major classes of proteins. Western blot analysis was used to determine the relative amount of AS in affinity-purified protein complexes derived from cells treated with rotenone versus vehicle. As expected, AS increased significantly in cells treated with rotenone (ϳ250% increase over controls).
Confirmation of Association of hsp70 with AS-
While high throughput proteomic analysis of AS-associated proteins identified candidate proteins for further study, the proteins identified by this approach require validation before their biological roles are pursued. It is obviously impractical to verify all the proteins listed in Supplementary Materials I or even the proteins listed in Table II . As a first step toward verifying proteins most likely to have biological importance, we chose hsp70, whose relative levels in AS protein complexes decreased significantly in rotenone-treated cells compared with controls. In addition, hsp70 regulation has been shown by others to modulate AS toxicity in vitro and in vivo. Thus we sought to determine (i) whether hsp70 was indeed associated with Nonidet P-40 soluble AS, and if so, (ii) whether there was a change in its relative abundance in rotenone-treated cells consistent with that observed using proteomic ICAT analysis. To accomplish these goals, samples were prepared using the same affinity purification protocol as for ICAT sample preparation and blotted with anti-hsp70. As shown in Fig. 4A, hsp70 was not only present in the AS complexes but also substantially reduced in AS complexes from rotenone-treated cells. We confirmed that equal amounts of protein were loaded in each lane (Fig. 4B) , indicating a loss in hsp70 relative to other proteins. Semiquantitative Western blot analysis indicated that the level of hsp70 decreased more than 500% compared with controls, in good agreement with our proteomic data showing an ϳ10-fold decrease in rotenone-treated cells versus controls.
As a further confirmation, cell extracts treated with rotenone were immunoprecipitated with anti-hsp70 and analyzed by Each doublet corresponds to a pair of ICAT-labeled peptides of identical sequence. The mass-to-charge (m/z) ratio difference between peptides is dependent on the charge state (number of hydrogen ions) and is typically 9.0 (a charge state of one), 4.5 (a charge state of two), or 3.0 (a charge state of three). B, expanded view of a full scan mass spectrum showing ion abundance for two identical peptides labeled with heavy and light ICAT reagents. C, MS/MS pattern with various b and y ions; these ions were searched against protein databases leading to an unequivocal identification of protein, hsp60. D, reconstructed ion chromatograms for the peptide ions measured in B with a newly developed computer algorithm, the ASAP ratio, which factors in the relative abundance of all peptides detected that correspond to a particular protein (77) .
FIG. 3. Major classes of AS-associated proteins.
This chart shows all identified proteins, ϳ20% of which do not have known functions. When a protein could be assigned to more than 1 class of functions, it was put in the best known class.
anti-AS Western blotting. Fig. 4C shows one distinct band corresponding to AS monomer and another that is likely an AS complex associated with other unspecified proteins. Taken together, these results demonstrated that hsp70 was not only associated with AS but also significantly decreased in the AS protein complexes of cells exposed to 20 nM rotenone for 3 days.
Transfection of hsp70 Prevented Rotenone-mediated Neurotoxicity and AS Aggregation-After confirming an hsp70-AS association using two independent methods, we tested whether overexpression of hsp70 could protect cells from the effects of rotenone. As shown in Fig. 5A, hsp70 transfection not only significantly protected cells from rotenone-mediated cytotoxic- ity but also appeared to significantly decrease formation of soluble AS aggregates ( Fig. 1C ). Of note, hsp70 transfection offered only partial protection by restoring viability to ϳ65% of controls. To determine whether the fraction of cells being protected was also overexpressing hsp70 at high levels, hsp70 expression and viability were simultaneously determined for cells treated with rotenone or vehicle using a FITC-TUNEL/hsp70 dual labeling system (Fig.  5C) . When hsp70 expression level was plotted as a function of number of dying (TUNEL-positive) cells, the results (shown in Fig. 5, C 1 and C 2 ) indicated that most viable cells had increased hsp70 expression whereas TUNEL-positive cells showed lower levels of hsp70 expression (represented by a shift of TUNEL negative cells (C 1 ) to TUNEL-positive cells (C 2 )).
Effects of hsp70 Transfection on Oxidative Stress, Mitochondrial Complex I Activity, and Proteasomal Function-It is well known that rotenone is a potent inhibitor of mitochondrial complex I, which in turn also produces significant oxidative stress and inhibits proteasomal function (18, 32) . To investigate whether hsp70 transfection also influenced these parameters while offering neuroprotection, we confirmed these effects of rotenone in our cell culture model and determined whether overexpression of hsp70 offered significant protection. Consistent with the observations of others, 20 nM rotenone treatment for 3 days significantly increased oxidative stress ( Fig. 6A ; 170% of control), suppressed mitochondrial complex I activity ( Fig. 6B; 10% of control) , and induced small but detectable inhibition of both chymotrypsin-like and glutamyl peptidase activities (Fig. 6C, ϳ90 and 85% of controls, respectively) in untransfected and vector-transfected cells. In contrast, hsp70 transfection significantly attenuated the oxidative stress and mitochondrial inhibition induced by rotenone (Fig. 6, A and B , p Ͻ 0.05). Notably, though oxidative stress induced by rotenone was totally suppressed, rescue of mitochondrial function was only ϳ50%. Finally, hsp70 transfection restored and even enhanced proteasomal function beyond that seen with controls (Fig. 6C) . Taken together, these results indicate that while oxidative stress and mitochondrial and proteasomal dysfunction are all interrelated, mitochondrial dysfunction may regulate cell function via pathways independent of the other two processes. Indeed, residual mitochondrial dysfunction in hsp70-transfected cells treated with rotenone correlated well with remaining cytotoxicity (Fig. 5A ) in the absence of oxidative stress as assessed by carbonyl contents and enhanced proteasomal function.
DISCUSSION
Several major findings emerged from this work. First, more than 250 proteins were identified in the protein complex associated with AS. Second, rotenone exposure caused neurotoxicity, resulted in LB-like cytoplasmic inclusions, and significantly modified the protein profile of AS complexes. Third, overexpression of hsp70, an AS-associated protein whose level decreased substantially when cells were treated with rotenone, significantly protected from rotenone-mediated cytotoxicity and formation of soluble AS aggregates. Finally, this neuroprotection afforded by hsp70 transfection was accompanied by enhanced proteasomal function, attenuated oxidative stress, and reduced mitochondrial dysfunction.
We used robust LC proteomics to identify more than 250 proteins associated with AS, the most complete characterization of the AS-associated proteome to date. Importantly, among 34 proteins reported in the literature to be associated with AS, LBs, or both, 17 co-purified with AS in our cells (Table I ). There are several explanations for why the remaining 17 were not identified in our study. First, some of them, e.g. BAD, CaM, and ubiquitin, do not contain any cysteine residues and thus are transparent to the ICAT method. Others, like parkin, were identified by one peptide but did not meet our criteria. Finally, not all proteins can be identified with the current state of MS technology. Nonetheless, while more extensive and integrated proteomic approaches are needed to fully characterize all the proteins interacting with AS, our experiments have identified many more novel proteins that have not yet been associated with AS. If validated, these proteins may reveal new mechanisms for PD development or provide new therapeutic targets for PD therapy.
As mentioned, proteomics functions best as a robust tool to identify potential candidate proteins for further study. However, caution needs to be exercised with novel proteins identified via affinity chromatography followed by MS identification because these proteins can stick to AS during affinity purification and become false positives. In addition, proteins may be identified incorrectly by MS due to currently incomplete databases. Hence, a major task for us in the next few years is to validate the true association of these candidate proteins with AS either directly or indirectly via docking proteins. Notably, despite the fact that most mitochondria were removed during affinity purification, there were still quite a few mitochondrial proteins identified in the AS protein complex (Supplementary Materials I). Because it is well established that among hundreds of mitochondrial proteins, only 13 peptides are coded by mitochondrial DNA (mtDNA) (33) , this means the majority of mitochondrial proteins are synthesized in the cytosol and transported into mitochondria via not well-characterized mech- FIG. 4 . Association of hsp70 and AS. A and B, samples were prepared exactly as described for ICAT experiments to isolate ASassociated proteins from cells treated with vehicle (0.1% Me 2 SO) or 20 nM rotenone (Rot) for 3 days. Following AS affinity purification, protein concentration was determined, and 5 g of protein from each sample were subjected to gel electrophoresis, followed by transfer to polyvinylidene difluoride and Western blotting with anti-hsp70 (A) or silver staining (B), which confirmed that an equal amount of protein was loaded in each lane. Optical densities of the hsp70 bands were quantified; hsp70 level in rotenone-treated cells decreased more than 500% over controls. C, reverse immunoprecipitation was performed in Nonidet P-40 soluble cell extracts using anti-hsp70 to immunoprecipitate hsp70 and associated proteins without affinity purification, followed by Western blot analysis using an anti-AS. Lane 1, immunoprecipitation with anti-hsp70, and lane 2, primary antibody was omitted in immunoprecipitation.
anisms. Thus, these proteins have the opportunity to interact with AS before being targeted to mitochondria. The fact that none of the proteins identified in the current study are encoded by mtDNA supports this hypothesis. Nonetheless, even with the most careful preparation, there is always the possibility of contamination, reemphasizing the point that all proteins identified by these approaches need to be validated as we did with hsp70. Of note, proteins with significant changes between two experimental settings (Table II) are less likely to be contaminants since contamination tends to be canceled out by this approach (16, 23, 34 ).
Hsp70 appears to be important in rotenone-mediated toxicity because its overexpression not only protected cells from cell death but also AS aggregation. Our results are largely in line with earlier observations showing that overexpression of hsp70 in Drosophila protected against AS-mediated toxicity (35) . The precise role of hsp70 in neuroprotection is not entirely clear, but hsps in general are critical elements in the cellular response to unfolded proteins and in promoting proper protein folding to prevent aggregation, as well as in promoting ubiquitination and degradation of misfolded proteins (36) . The fact that most proteins listed in Table II , including hsp70, decreased in their relative abundance in AS protein complexes when cells were treated with rotenone compared with vehicle supports the hypothesis that there is indeed molecular crowding of AS. In line with this argument, AS levels, as assessed by Western blot analysis, were significantly increased in AS complex. This local crowding of AS molecules after rotenone treatment likely facilitates AS aggregation. Overexpression of hsp70 may have attenuated rotenone-induced molecular crowding of AS, thereby preventing AS aggregation as well as cell death.
Another protein that may have played a major role in molecular crowding of AS is hsp90, whose level significantly increased in the AS protein complex when cells were treated with rotenone. One interpretation would be that hsp90 interacts with AS or its associated proteins to enhance molecular crowding and subsequent AS aggregation and cell death. Support for this hypothesis can be found in another earlier study showing that geldanamycin, a naturally occurring benzoquinone ansamycin that specifically binds to and interferes with the activity of hsp90, completely prevented AS-induced toxicity in Drosophila (37) . An obvious follow-up for us would be to overexpress or silence hsp90 to see whether this exacerbates or prevents AS aggregation, respectively. The same could be done for other proteins whose levels changed significantly after rotenone treatment.
A few other candidate proteins, particularly those that displayed major alternations in relative protein abundance between controls and cells treated with rotenone (Table II) , are also worth noting. They include 14-3-3, a molecular chaperone that appears to interact with a variety of ligands and cellular proteins and thus modify their activities, and tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis (38) . More recent observation has suggested that AS not only interacts with TH, but also inhibits TH activity. In fact, it has been proposed that loss of soluble AS due to AS aggregation may result in TH hyperactivity and elevation of dopamine, leading to vulnerability of these neurons (39) .
Furthermore, the fact that 35% of proteins identified (Fig. 3 ) are related to signal transduction (e.g. MAP1A, B, MAP2, MAPKs, ERKs, PKCs, and calcium/calmodulin-dependent protein kinase) and 10% to UPS function (e.g. UCH-L1, proteasome subunit ␣, ␤, and 26 S proteasome regulatory subunits) suggests that AS interacts with these proteins to execute its function. However, detailed mechanistic studies will require other experimental systems. Finally, although the current study is focused on proteins associated with AS, other biomolecules such as membranous lipids may also interact with AS, thereby modifying its function (40) .
It has been well demonstrated that the mechanism(s) of rotenone-mediated neurotxocity involves inhibition of mitochondrial complex I and production of oxidative stress, ultimately leading to AS aggregation and neuronal degeneration. Our current study not only confirmed these results but also demonstrated that hsp70 transfection can significantly prevent rotenone-mediated AS aggregation and neuronal degeneration, as well as rotenone-mediated mitochondrial inhibition and oxidative stress. In addition, proteasomal function appeared to be enhanced by hsp70 overexpression. Taken together, these data suggest (i) that oxidative stress, mitochondrial function, and proteasomal function are interrelated and (ii) that hsp70 may interact with AS directly or with its associated proteins to affect these factors and ultimately modulate molecular crowding, AS aggregation, and neurodegeneration.
In summary, we have used a robust proteomic technique to characterize proteins associated with AS in dopaminergic cells with and without formation of LB-like inclusions and demonstrated that transfection of hsp70, an AS-associated protein, not only protected cells from rotenone-mediated neurotoxicity but also attenuated rotenone-induced oxidative stress and mitochondrial and proteasomal dysfunction. These results suggest an interaction between proteins involved in various processes related to PD, thereby influencing AS aggregation and ultimately cell death.
